P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE

ABSTRACT:

SUBMITTER: Roost Clausen M 

PROVIDER: S-EPMC10431001 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature